COLISTIN CF

Glavne informacije

  • Zaščiteno ime:
  • COLISTIN CF
  • Farmacevtska oblika:
  • prašek za inhaliranje
  • Pot uporabe:
  • Način uporabe nedoločen
  • Enote v paketu:
  • škatla s 56 vialami praška in 56 ampulami s 3 ml topila (0,9% NaCl)
  • Tip zastaranja:
  • / - Način/režim izdaje ni določen.
  • Uporabi za:
  • ljudje
  • Vrsta medicine:
  • Alopatska drog

Dokumentov

Lokalizacija

  • Na voljo v:
  • COLISTIN CF
    Slovenija
  • Jezik:
  • slovenščina

Terapevtski podatki

  • Terapevtska skupina:
  • kolistin

Drugi podatki

Stanje

  • Source:
  • JAZMP - Javna agencija RS za zdravila in medicinske pripomočke - Slovenia Medicines Agency
  • Status dovoljenje:
  • Zdravilo z začasnim dovoljenjem za vnos/uvoz za posamično zdravl
  • Datum dovoljenje:
  • 23-06-2009
  • Zadnja posodobitev:
  • 19-01-2018

11-2-2015

Send Danish package leaflet when applying for changes to product information

Send Danish package leaflet when applying for changes to product information

When applying for changes to the product information, marketing authorisation holders must always send a Danish version of the package leaflet to the Danish Health and Medicines Authority, whether the medicinal product is marketed in Denmark or not (unless the medicinal product is subject to section 11 about omission of the package leaflet, cf. Executive order no. 869 of 21 July 2011, as amended, on the labelling etc. of medicinal products).

Danish Medicines Agency

18-12-2006

Reassessment of reimbursement status of the remaining subgroups of ATC group C

Reassessment of reimbursement status of the remaining subgroups of ATC group C

The Danish Medicines Agency previously notified companies and a number of scientific societies and patient organisations about which ATC groups and subgroups would be the first to be reassessed, cf. the fact box to the right.

Danish Medicines Agency

Ni novosti v zvezi s tem izdelkom